| Source Date | Board Meeting Date | Details |
|
04-Feb-2025
|
11-Feb-2025
|
Quarterly Results
|
|
07-Nov-2024
|
13-Nov-2024
|
Quarterly Results
|
|
05-Aug-2024
|
09-Aug-2024
|
1. The Un -Audited Financial Results(Standalone) for the Quarter ended June 30, 2024. 2. To fix the time & date of the 34th Annual General Meeting of the Company. & Audited Results & A.G.M.
|
|
16-May-2024
|
22-May-2024
|
Audited Results
|
|
01-Feb-2024
|
07-Feb-2024
|
Quarterly Results
|
|
29-Dec-2023
|
04-Jan-2024
|
Inter alia, to consider and approve:- 1) Allotment of 124,00,000 convertible warrants into equivalent equity shares of the company to promoters and non-promoter entity at a price of Rs. 45/- (including premium of Rs. 35/- per equity warrant) per equity warrant on a preferential basis in accordance with the special resolution passed in Extra Ordinary General Meeting held on 07th December, 2023. 2) Any other matter with the prior permission of the chair.
|
|
02-Nov-2023
|
08-Nov-2023
|
Quarterly Results & Preferential Issue of shares & Inter alia, to consider and approve the following business: 1) To consider, approve and evaluate the proposal for fund raising by way of issue of any instrument or securities through qualified institutional placement, private placement/ preferential issue of securities or through any other permissible mode and/ or combination thereof as may be considered appropriate, in accordance with the provision of Companies Act, 2013 and SEBI (Issue Of Capital & Disclosure Requirements) Regulations, 2018, as amended, subject to such regulatory approvals as may be required including the approval of the members at a General Meeting and further subject to such statutory/regulatory approvals, as applicable. In case the fund raising is approved in the meeting, the compa
|
|
14-Jul-2023
|
20-Jul-2023
|
Quarterly Results & A.G.M.
|
|
09-May-2023
|
15-May-2023
|
Audited Results
|
|
01-Feb-2023
|
08-Feb-2023
|
Quarterly Results
|